Evaluation of the safety and efficacy of peripheral vasopressors to decrease central line placement and associated bloodstream infections.

Background: In 2020, as a result of evidence of demonstrated safety of an initial pilot program, our institution set out to implement a peripheral vasopressor infusion protocol.

Objective: To evaluate the use of peripheral lines for vasopressor administration to reduce placement of unnecessary central lines and central line days.

Methods: This is an Institutional Review Board approved, single center retrospective chart review conducted as pre/post-analysis.